Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · IEX Real-Time Price · USD
85.49
+0.09 (0.11%)
At close: Jul 19, 2024, 4:00 PM
85.54
+0.05 (0.06%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for MMSI stock have an average target of 93.2, with a low estimate of 70 and a high estimate of 125. The average target predicts an increase of 9.02% from the current stock price of 85.49.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MMSI stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 5 | 5 |
Hold | 3 | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 10 | 9 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barrington Research | Barrington Research | Buy Maintains $100 | Buy | Maintains | $100 | +16.97% | Jul 16, 2024 |
Barrington Research | Barrington Research | Buy Maintains $100 | Buy | Maintains | $100 | +16.97% | Jul 2, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $102 → $125 | Strong Buy | Maintains | $102 → $125 | +46.22% | Jul 2, 2024 |
Needham | Needham | Strong Buy Maintains $85 → $93 | Strong Buy | Maintains | $85 → $93 | +8.78% | Jul 1, 2024 |
Baird | Baird | Buy Initiates $96 | Buy | Initiates | $96 | +12.29% | Jun 28, 2024 |
Financial Forecast
Revenue This Year
1.35B
from 1.26B
Increased by 7.37%
Revenue Next Year
1.42B
from 1.35B
Increased by 5.48%
EPS This Year
3.40
from 1.62
Increased by 109.80%
EPS Next Year
3.71
from 3.40
Increased by 9.21%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 1.4B | 1.5B | 1.6B | 1.6B |
Avg | 1.4B | 1.4B | 1.5B | 1.6B |
Low | 1.3B | 1.4B | 1.4B | 1.5B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 10.9% | 9.3% | 9.9% | 9.5% |
Avg | 7.4% | 5.5% | 5.5% | 6.4% |
Low | 2.8% | 0.5% | 0.1% | 2.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 3.52 | 3.97 | 4.36 | 4.82 | 5.21 |
Avg | 3.40 | 3.71 | 4.09 | 4.42 | 5.06 |
Low | 3.24 | 3.39 | 3.72 | 4.00 | 4.86 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 117.1% | 16.8% | 17.4% | 17.9% | 17.8% |
Avg | 109.8% | 9.2% | 10.1% | 8.2% | 14.4% |
Low | 100.2% | -0.2% | 0.3% | -2.2% | 9.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.